UBS Group’s MDH Acquisition Corp. Units, each consisting of one share of Class A Common Stock, and one-half of one redeemable warrant MDH.U Stock Holding History

UBS Group’s Portfolio MDH.U Stock Details MDH.U Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2,013	Closed	-$20K	–	11574
2022 Q3	$20K	Sell	2,013 -66	-3%	-$650	﹤0.01%	7441
2022 Q2	$20K	Buy	2,079 +1,114	+115%	+$11K	﹤0.01%	6915
2022 Q1	$9K	Hold	965	–	–	﹤0.01%	8616
2021 Q4	$10K	Sell	965 -1,100	-53%	-$11.1K	﹤0.01%	8847
2021 Q3	$21K	Buy	2,065 +661	+47%	+$6.67K	﹤0.01%	7138
2021 Q2	$14K	Buy	1,404 +400	+40%	+$4K	﹤0.01%	7740
2021 Q1	$10K	Buy	+1,004	New	+$10.2K	﹤0.01%	7959

Other funds holding MDH.U

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group's MDH.U Position: Q4 2022 in Review

UBS Group sold out of MDH Acquisition Corp. Units, each consisting of one share of Class A Common Stock, and one-half of one redeemable warrant (MDH.U) in Q4 2022, closing a stake of 2,013 shares — an estimated $20K sold.

UBS Group first reported a position in MDH.U in Q1 2021 and held it in 7 quarters. The position peaked at $21K in Q3 2021. 2 funds tracked by Wall St. Rank hold MDH.U as of Q4 2022.

UBS Group reported no remaining MDH Acquisition Corp. Units, each consisting of one share of Class A Common Stock, and one-half of one redeemable warrant position as of Q4 2022 after selling out during the quarter.
UBS Group sold 2,013 MDH Acquisition Corp. Units, each consisting of one share of Class A Common Stock, and one-half of one redeemable warrant shares in Q4 2022, an estimated $20K.
UBS Group first reported a position in MDH Acquisition Corp. Units, each consisting of one share of Class A Common Stock, and one-half of one redeemable warrant in Q1 2021 and held it in 7 quarters.
UBS Group's MDH Acquisition Corp. Units, each consisting of one share of Class A Common Stock, and one-half of one redeemable warrant position peaked at $21K in Q3 2021.
2 funds tracked by Wall St. Rank held MDH Acquisition Corp. Units, each consisting of one share of Class A Common Stock, and one-half of one redeemable warrant as of Q4 2022.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.